SLB
39
2
ADM
36
2
DNB
54
-2
MOS
42
3
EMC
40
-2
AME
45
-2
EL
15
-2
MSI
50
-8
HUM
34
-2
CHD
42
-6
CSX
33
-3
AEP
70
-2
MS
55
-2
NOC
57
4
ETN
49
-4
LMT
42
5
EFX
55
-3
MTB
50
-2
OMC
32
-8
EMR
37
-3
SLB
39
2
ADM
36
2
DNB
54
-2
MOS
42
3
EMC
40
-2
AME
45
-2
EL
15
-2
MSI
50
-8
HUM
34
-2
CHD
42
-6
CSX
33
-3
AEP
70
-2
MS
55
-2
NOC
57
4
ETN
49
-4
LMT
42
5
EFX
55
-3
MTB
50
-2
OMC
32
-8
EMR
37
-3
Financhill
Back

Soleno Therapeutics Stock Predictions

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
68

SLNO
Soleno Therapeutics

Last Price:
$70.00
Seasonality Move:
5.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Market's down 10% YTD Buffet's Berkshire up 13%

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Soleno Therapeutics Stock Forecast

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 92.2% based on the past 10 years of stock performance.
  • Soleno Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Soleno Therapeutics Stock Undervalued?
    The current Soleno Therapeutics [SLNO] share price is $69.93. The Score for SLNO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • SLNO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Soleno Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Soleno Therapeutics has on average historically risen by 92.2% based on the past 10 years of stock performance.

Soleno Therapeutics Stock Rating

Buy
68
Soleno Therapeutics (SLNO) is a Buy

Is Soleno Therapeutics overpriced?

  • Soleno Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Soleno Therapeutics Stock Price History

Is SLNO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLNO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
soleno.life

52-Week Data

52-Week High:
74.00
52-Week Low:
36.61

Prediction Charts

Market Cap:
3.2B
Price in USD:
69.93
Volume:
1M
Beta:
-0.34

Technical Analysis

SMA50:
53.98
SMA100:
51.16
SMA200:
50.58
52-Wk Change:
85.05%

Stock Predictions

  • Is Soleno Therapeutics stock public?
    Yes, Soleno Therapeutics is a publicly traded company.
  • What is the Soleno Therapeutics stock quote today?
    The Soleno Therapeutics stock price is 69.93 USD today.
  • How to buy Soleno Therapeutics stock online?
    You can buy Soleno Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-28 67.83 71.99 73.97 66.90
Mar-31 71.54 71.45 73.94 69.87
Apr-1 70.11 68.26 71.29 66.50
Apr-2 67.53 73.67 73.96 66.60
Apr-3 71.38 72.16 74.00 70.37
Apr-4 71.39 67.48 73.00 67.13
Apr-7 66.04 69.64 69.97 64.00
Apr-8 69.92 59.04 71.46 59.00
Apr-9 58.01 63.27 65.35 57.01
Apr-10 61.45 62.87 64.64 59.48
Apr-11 62.71 67.23 67.37 62.11
Apr-14 67.97 70.00 70.40 66.12
Apr-15 69.79 70.25 70.36 68.27
Apr-16 69.85 69.93 71.00 68.45

Soleno Therapeutics Earnings

Soleno Therapeutics Earnings Report: Per Share Soleno Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Soleno Therapeutics Forecast Revenue Growth

Soleno Therapeutics Stock Analysis: Historical quarterly revenues per share for Soleno Therapeutics and historical quarterly revenue growth:

* Soleno Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.